Lisata Therapeutics, Inc.
LSTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $22,894 | $24,955 | $20,215 | $24,820 |
| - Cash | $18,998 | $16,835 | $20,217 | $16,209 |
| + Debt | $0 | $47 | $92 | $137 |
| Enterprise Value | $3,896 | $8,167 | $90 | $8,748 |
| Revenue | $0 | $70 | $0 | $1,000 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | $0 | $70 | $0 | $1,000 |
| % Margin | – | 100% | – | 100% |
| EBITDA | -$4,205 | -$4,615 | -$5,804 | -$4,908 |
| % Margin | – | -6,592.9% | – | -490.8% |
| Net Income | -$4,249 | -$4,659 | -$4,724 | -$4,610 |
| % Margin | – | -6,655.7% | – | -461% |
| EPS Diluted | -0.49 | -0.54 | -0.55 | -0.55 |
| % Growth | 9.3% | 1.8% | 0% | – |
| Operating Cash Flow | -$3,342 | -$3,956 | -$5,402 | -$4,528 |
| Capital Expenditures | $0 | -$28 | -$28 | $0 |
| Free Cash Flow | -$3,342 | -$3,984 | -$5,430 | -$4,528 |